US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Phytonadione Tablets 5 mg

Reason Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.

AVKARE Inc. NDC 50268-661-13 D-0631-2021
Class III · Low risk Terminated

Ketamine HCl Injection Solution

Reason Labeling: Incorrect Exp. Date: Incorrect BUD.

Prisma Health Outsourcing Facility D-0648-2021
Class III · Low risk Terminated

Phytonadione Tablets

Reason Failed Impurities/Degradation Specifications

Bausch Health Companies, Inc. NDC 68682-170-30 D-0639-2021
Class III · Low risk Terminated

Mephyton

Reason Failed Impurities/Degradation Specifications

Bausch Health Companies, Inc. NDC 0187-1704-05 D-0638-2021
Class III · Low risk Terminated

Atorvastatin Calcium Tablets

Reason Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities

Dr. Reddy's Laboratories, Inc. NDC 55111-121-05 D-0629-2021
Class III · Low risk Terminated

Levetiracetam Tablets USP

Reason Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam

McKesson Corporation dba McKesson Drug Company NDC 63739-795-10 D-0630-2021
Class III · Low risk Terminated

Readyprep Chg

Reason Superpotent Drug: Product is above specification for active ingredient, 2% Chlorhexidine Gluconate.

Medline Industries Inc D-0624-2021
Class III · Low risk Terminated

Sirolimus Tablets 1 mg

Reason Failed Impurities/Degradation Specifications

American Health Packaging NDC 68084-915-25 D-0813-2021
Class III · Low risk Terminated

Cequa

Reason Subpotent and Presence of Particulates .

Sun Pharmaceutical Industries INC NDC 47335-506-96 D-0391-2021
Class III · Low risk Terminated

Atorvastatin Calcium Tablets

Reason Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

Dr. Reddy's Laboratories, Inc. NDC 55111-121-05 D-0599-2021
Class III · Low risk Terminated

Thiamine HCl Injection

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.

Mylan Institutional LLC D-0601-2021
Class III · Low risk Terminated

Olmesartan Medoxomil Tablets

Reason Presence of Foreign Tablet/Capsule

Ascend Laboratories LLC NDC 67877-446-30 D-0392-2021
Class III · Low risk Terminated

Acyclovir Tablets

Reason Labeling: Incorrect or Missing Lot and/or Exp Date

Heritage Pharmaceuticals Inc NDC 23155-227-01 D-0367-2021
Class III · Low risk Terminated

Evrysdi

Reason Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.

Genentech Inc D-0357-2021
Class III · Low risk Terminated

Asenapine Sublingual Tablets

Reason Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

SigmaPharm Laboratories LLC NDC 42794-017-10 D-0380-2021
Class III · Low risk Terminated

Asenapine Sublingual Tablets

Reason Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

SigmaPharm Laboratories LLC NDC 42794-016-10 D-0379-2021
Class III · Low risk Terminated

Dry Eye Test

Reason Subpotent Drug

Nomax Inc D-0387-2021